Funded Tech Companies
HexemBio
HexemBio is a life sciences company, based in New York. VC investment was provided by Draper Associates, SOSV and Seraphim Capital.
Company Overview
Company Name
HexemBio
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
7 Pennsylvania Plaza, 9th Floor
New York, NY 10001
USA
New York, NY 10001
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
HexemBio is developing regenerative therapies based on the Synthetic Human Yolk Sac, a technology designed to rejuvenate aging blood stem cells by recreating the developmental environment where they first arise. By restoring the regenerative capacity of a patient's own hematopoietic stem cells, HexemBio aims to improve outcomes in bone marrow transplantation and unlock new approaches to extending human healthspan. The company received FDA Orphan Drug Designation in July 2025 and completed its FDA Pre-IND meeting in January 2026. Founded in 2024, HexemBio operates from New York City and from Berkeley.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/6/2026
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gabriel Tremblay
Chief Scientific Officer
Mo EbrahimkhaNI
Chief Technical Officer
Samira Kiani
Co-Founder
Joshua Hislop
VP - Bus. Development
Samet Yildirim
Company Investors
Browse more funded tech companies:
Hexaware Technologies | Hexify
Share this article
About Our VC & M&A Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs